Tag: Safety

How will you mark AORN’s National Time Out Day?

Editor's Note AORN encourages perioperative leaders to speak up and reach out in honor of National Time Out Day, an annual recognition of the critical safety practice scheduled for June 12. The annual day of recognition draws attention to the need for everyone on the surgical team to pause before…

Read More

By: Matt Danford
June 10, 2024
Share

Study: standard preoperative fasting guidelines safe for GLP-1 patients

Editor's Note Preoperative use of GLP-1 receptor agonists (RA) medications such as Ozempic and Wegovy is safe, according to a study published in the June issue of the American Journal of Gastroenterology. Controversy has swirled around these drugs due to the risk of slowed stomach emptying increasing a patient’s odds…

Read More

By: Matt Danford
June 7, 2024
Share

AI promises to eliminate unnecessary breast cancer biopsies

Editor's Note An AI model that outperformed MRI and ultrasound in identifying patients with axillary breast cancer metastasis shows the technology’s potential to reduce the need for needle or surgical biopsies, according to developers at UT Southwestern Medical Center. In a May 21 report on their new AI model, researchers…

Read More

By: Matt Danford
June 6, 2024
Share

Ascension set to restore electronic health record after cyberattack

Editor's Note Ascension, a 140-hospital, St. Louis-based health system disrupted by a May 8 cyberattack, has announced that its electronic medical record (EHR) will be restored by June 14. Becker’s Health IT reported the news June 5. According to that article, the restoration of systems comes after medical records have…

Read More

By: Matt Danford
June 6, 2024
Share

FDA designates Class I recall for neurosurgery software

Editor's Note The US Food & Drug Administration (FDA) has classified Medtronic’s recall of its StealthStation S8 software as a Class I, the most severe category indicating risk of serious injury or death. The StealthStation System with StealthStation Cranial software is intended as an aid for locating anatomical structures during…

Read More

By: Matt Danford
June 5, 2024
Share

Hospital margins, ED visits up, length of stay down in April, Kaufman report reveals

Editor's Note The median hospital margin of 3.8% for April is an improvement over the previous month and year-over-year, according to the latest National Hospital Flash Report from Kaufman Hall. Compiled by Kaufman and Syntellis Performance Solutions (now part of Strata), the monthly report analyzes 3 years’ worth of both…

Read More

By: Matt Danford
June 4, 2024
Share

Dialysis patients feasible for kidney donation, transplant outcome study suggests

Editor's Note A retrospective cohort study found transplanting kidneys from donors who underwent dialysis resulted in no long-term differences in graft failure, kidney function, or death, but recipients had significantly higher risk for delayed graft function (DGF). According to a May 23 MedPage Today report on the study, originally published…

Read More

By: Matt Danford
June 3, 2024
Share

HHS: Change Healthcare responsible for cyberattack data breach notifications

Editor's Note Change Healthcare is responsible for notifying affected parties about privacy breaches resulting from the February cyberattack on the company, The U.S. Department of Health and Human Services (HHS) announced May 31. The announcement took the form of an update to an FAQ webpage from HHS’ Office for Civil…

Read More

By: Matt Danford
June 3, 2024
Share

Class 1 recall announced for ambulatory infusion pump

Editor's Note The US Food and Drug Administration (FDA) has designated OptumHealth Care Solutions’ recall of the Nimbus II ambulatory infusion pumps a class 1, the most severe category indicating risk of serious injury or death. According to the agency’s May 30 announcement, the company recalled the pumps in direct…

Read More

By: Matt Danford
May 31, 2024
Share

Surgery benefits transplant-ineligible HCC patients more than less invasive options

Editor's Note Liver resection provides a significant survival benefit over percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE) in patients with early multinodular hepatocellular carcinoma (HCC), according to findings published May 15 in JAMA Surgery. Thus, liver resection should be considered the first therapeutic option in patients with early multinodular…

Read More

By: Matt Danford
May 29, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat